Suppr超能文献

意大利经皮腔内腹主动脉瘤修复术(IPER)注册研究:2381例经皮股动脉入路用于主动脉覆膜支架置入术后穿刺部位闭合的结果

Italian Percutaneous EVAR (IPER) Registry: outcomes of 2381 percutaneous femoral access sites' closure for aortic stent-graft.

作者信息

Pratesi G, Barbante M, Pulli R, Fargion A, Dorigo W, Bisceglie R, Ippoliti A, Pratesi C

机构信息

Unit of Vascular Surgery, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy -

出版信息

J Cardiovasc Surg (Torino). 2015 Dec;56(6):889-98. Epub 2015 Sep 15.

Abstract

AIM

The aim of this paper was to report outcomes of endovascular aneurysm repair with percutaneous femoral access (pEVAR) using Prostar XL and Proglide closure systems (Abbot Vascular, Santa Clara, CA, USA), from the multicenter Italian Percutaneous EVAR (IPER) registry.

METHODS

Consecutive patients affected by aortic pathology treated by EVAR with percutaneous access (pEVAR) between January 2010 and December 2014 at seven Italian centers were enrolled in this multicenter registry. All the operators had an experience of at least 50 percutaneous femoral access procedures. Data were prospectively collected into a dedicated online database including patient's demographics, anatomical features, intra- and postoperative outcomes. A retrospective analysis was carried out to report intraoperative and 30-day technical success and access-related complication rate. Uni- and multivariate analyses were performed to identify factors potentially associated with an increased risk of percutaneous pEVAR failure.

RESULTS

A total of 2381 accesses were collected in 1322 patients, 1249 (94.4%) male with a mean age of 73.5±8.3 years (range 45-97). The overall technical success rate was 96.8% (2305/2381). Major intraoperative access-related complications requiring conversion to surgical cut-down were observed in 3.2% of the cases (76/2381). One-month pEVAR failure-rate was 0.25% (6/2381). Presence of femoral artery calcifications resulted to be a significant predictor of technical failure (OR: 1.69; 95% CI: 1.03-2.77; P=0.036) at multivariate analysis. No significant association was observed with sex (P=0.28), obesity (P=0.64), CFA diameter (P=0.32), level of CFA bifurcation (P=0.94) and sheath size >18 F (P=0.24). The use of Proglide was associated with a lower failure rate compared to Prostar XL (2.5% vs. 3.3%) despite not statistically significant (P=0.33).

CONCLUSION

The results of the IPER registry confirm the high technical success rate of percutaneous EVAR when performed by experienced operators, even in presence of demanding anatomies. Femoral calcification represents the only predictor of percutaneous access failure.

摘要

目的

本文旨在报告来自意大利多中心经皮腔内腹主动脉瘤修复术(IPER)登记处,使用Prostar XL和Proglide闭合系统(美国加利福尼亚州圣克拉拉市雅培血管公司)经皮股动脉入路行腔内腹主动脉瘤修复术(pEVAR)的结果。

方法

2010年1月至2014年12月期间,在意大利七个中心接受经皮入路行腔内腹主动脉瘤修复术(pEVAR)治疗的连续性主动脉病变患者被纳入该多中心登记处。所有术者均至少有50例经皮股动脉入路手术的经验。数据被前瞻性收集到一个专用的在线数据库中,包括患者的人口统计学资料、解剖学特征、术中和术后结果。进行回顾性分析以报告手术中和30天的技术成功率及与入路相关的并发症发生率。进行单因素和多因素分析以确定可能与经皮pEVAR失败风险增加相关的因素。

结果

共收集了1322例患者的2381次入路数据,其中男性1249例(94.4%),平均年龄73.5±8.3岁(范围45 - 97岁)。总体技术成功率为96.8%(2305/2381)。3.2%的病例(76/2381)观察到需要转为手术切开的主要术中入路相关并发症。1个月的pEVAR失败率为0.25%(6/2381)。多因素分析显示,股动脉钙化是技术失败的显著预测因素(OR:1.69;95%CI:1.03 - 2.77;P = 0.036)。未观察到与性别(P = 0.28)、肥胖(P = 0.64)、股总动脉直径(P = 0.32)、股总动脉分叉水平(P = 0.94)和鞘管尺寸>18F(P = 0.24)有显著关联。与Prostar XL相比,使用Proglide的失败率较低(2.5%对3.3%),尽管无统计学意义(P = 0.33)。

结论

IPER登记处的结果证实,由经验丰富的术者进行经皮腔内腹主动脉瘤修复术时,即使存在复杂解剖结构,技术成功率也很高。股动脉钙化是经皮入路失败的唯一预测因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验